نتایج جستجو برای: nccn

تعداد نتایج: 961  

Journal: :Journal of the National Comprehensive Cancer Network : JNCCN 2006
Therese B Bevers Benjamin O Anderson Ermelinda Bonaccio Patrick I Borgen Saundra Buys Mary B Daly Peter J Dempsey William B Farrar Irving Fleming Judy E Garber Randall E Harris Mark Helvie Susan Hoover Helen Krontiras Sara Shaw Eva Singletary Celette Sugg Skinner Mary Lou Smith Theodore N Tsangaris Elizabeth L Wiley Cheryl Williams

Overview Women in the United States have a 12.3% estimated lifetime risk for developing breast cancer (i.e., 1 in 8 women).1 In 2009, an estimated 194,290 cases of invasive breast cancer (192,370 women and 1919 men) and 62,280 cases of female carcinoma in situ of the breast will be diagnosed in the United States, with 40,610 deaths from invasive breast cancer predicted.2 However, mortality from...

Journal: :Oncology nursing forum 2010
Anita Nirenberg Nancy K Reame Kenrick D Cato Elaine L Larson

PURPOSE/OBJECTIVES To describe oncology nurses' use of National Comprehensive Cancer Network (NCCN) clinical practice guidelines for chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN). DESIGN Cross-sectional survey design; descriptive, correlational analysis. SETTING E-mail invitation to Web-based survey. SAMPLE Random sample of 309 Oncology Nursing Society (ONS) members ...

Journal: :Astronomy and Astrophysics 2022

The previous detection of two species related to the nonpolar molecule cyanogen (NCCN), its protonated form (NCCNH + ) and one metastable isomer (CNCN), in cold dense clouds supported hypothesis that dicyanopolyynes are abundant space. Here we report first identification space NC 4 NH . This cation is N, which second member series after NCCN. was based on observation six harmonically lines with...

2015
Patricia R. Blank Martin Filipits Peter Dubsky Florian Gutzwiller Michael P. Lux Jan C. Brase Karsten E. Weber Margaretha Rudas Richard Greil Sibylle Loibl Thomas D. Szucs Ralf Kronenwett Matthias Schwenkglenks Michael Gnant

BACKGROUND The individual risk of recurrence in hormone receptor-positive primary breast cancer patients determines whether adjuvant endocrine therapy should be combined with chemotherapy. Clinicopathological parameters and molecular tests such as EndoPredict(®) (EPclin) can support decision making in patients with estrogen receptor-positive, human epidermal growth factor receptor 2 (HER2)-nega...

Journal: :The American journal of managed care 2005
John Hornberger Leon E Cosler Gary H Lyman

OBJECTIVE To appraise the economics of a recurrence score (RS), based on an assay that predicts distant recurrence-free survival in lymph-node-negative (LN-), estrogen-receptor-positive (ER+) patients with early-stage breast cancer receiving tamoxifen. STUDY DESIGN Cost-utility analyses using a decision analytic model. METHODS Using a Markov model, we forecast overall survival, costs, and c...

Journal: :Archives of surgery 2008
Karl Y Bilimoria Mark S Talamonti Jeffrey D Wayne James S Tomlinson Andrew K Stewart David P Winchester Clifford Y Ko David J Bentrem

HYPOTHESIS For gastric and pancreatic cancer, regional lymph node evaluation is important to accurately stage disease in a patient and may be associated with improved survival. We hypothesized that National Comprehensive Cancer Network (NCCN), National Cancer Institute (NCI)-designated institutions, and high-volume hospitals examine more lymph nodes for gastric and pancreatic malignant neoplasm...

2017
Ho-Young Yhim Jeong-A Kim Sun-Hye Ko Youngrok Park Eunjung Yim Hee Sun Kim Jae-Yong Kwak

Despite their critical roles in angiogenesis and host immunosuppression within the tumor microenvironment, the prognostic significance of myeloid-lineage cells expressing CD11b and CX3CR1 in diffuse large B-cell lymphoma (DLBCL) has not been well studied. We prospectively enrolled newly-diagnosed DLBCL patients at two Korean institutions between May 2011 and Aug 2015. CD11b+CX3CR1+ cells were a...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004
L E Cosler J Hornberger G H Lyman

6036 Background: Guidelines for LN-, ER+ adjuvant therapy stratify women into risk categories to optimize decisions concerning adjuvant CT use. A 21 gene RT-PCR assay, Oncotype DX™ Recurrence Score (RS), has been prospectively validated as a predictor of distant recurrence-free survival (DRFS) in the NSABP B-14 study of 668 evaluable LN-, ER+ patients receiving tamoxifen (Paik et al, SABCS 2003...

Journal: :Journal of the National Comprehensive Cancer Network 2018

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید